Alexza Pharmaceuticals has announced the hire of Robert A. Lippe as Executive VP, Operations and Chief Operations Officer. Lippe was most recently Head of Global Operations & Operational Excellence at Ironwood Pharmaceuticals.
The company is in the process of commercializing its Adasuve Staccato inhaled loxapine, which began its launch in Europe in the summer of 2013 and which will be marketed by Teva in the US.
Alexza President and CEO Thomas B. King said, “We are pleased to welcome Rob to our senior management team. Rob brings an extensive set of operational skills, along with a strategic sense and outlook. We look forward to his contributions as we continue the growth of the company through the global launch of Adasuve and expansion of our product candidate pipeline.”
Read the Alexza press release.
